Imagine a world where the shortage of organ donors is no longer a crisis. Sounds like science fiction, right? But groundbreaking research is bringing us closer to this reality by exploring the possibility of growing human organs in other species. A recent study led by UT Southwestern Medical Center has uncovered a critical barrier to this ambitious goal—and it’s all about an unexpected immune reaction. Here’s the fascinating part: when human pluripotent stem cells (PSCs) are grown alongside PSCs from distantly related species like mice or rats, the human cells often fail to survive. But here’s where it gets controversial: the study reveals that this failure isn’t due to some incompatibility between species but rather an innate immune response in the nonhuman cells, specifically targeting foreign RNA molecules. This discovery, published in Cell, could revolutionize how we approach organ transplantation.
Jun Wu, Ph.D., Associate Professor of Molecular Biology at UT Southwestern, explains, ‘Our ultimate goal is to use human PSCs to generate organs and tissues in animals, addressing the global organ donor shortage. This research highlights a previously overlooked role of RNA innate immunity in cell competition and interspecies chimerism, which has been a major roadblock.’ Dr. Wu co-led the study with Yingying Hu, Ph.D., and Masahiro Sakurai, Ph.D., shedding light on a process that could transform regenerative medicine.
And this is the part most people miss: In 2021, Dr. Wu’s team observed that human PSCs struggled to survive when co-cultured with mouse or rat PSCs. While genetic tweaks could help human cells endure, these modifications might compromise the safety of organs intended for transplant. Instead, the team focused on understanding why nonhuman cells seemed to outcompete their human counterparts. By comparing gene expression in mouse cells grown alone versus those co-cultured with human cells, they discovered the retinoic acid-inducible gene I-like receptor (RLR) pathway was hyperactive in the co-cultured mouse cells. This pathway, typically triggered by viral infections, was mistakenly attacking human RNA molecules exchanged between cells via tunneling nanotubes (TNTs).
When researchers disabled the RLR pathway by turning off the gene responsible for producing the mitochondrial antiviral signaling protein (MAVS), human cell survival rates soared. Similarly, injecting human cells into mouse embryos lacking MAVS resulted in significantly higher survival rates. These findings not only explain why human cells struggle in interspecies co-cultures but also provide actionable targets to improve their survival.
Here’s the bold question: Could this research pave the way for growing fully functional human organs in animals? While the ethical and technical challenges are immense, this study marks a pivotal step forward. Dr. Wu’s work, supported by grants from institutions like the Cancer Prevention and Research Institute of Texas and the New York Stem Cell Foundation, underscores the potential of stem cell research to redefine medicine.
But what do you think? Is growing human organs in animals a groundbreaking solution to the donor shortage, or does it raise ethical concerns that outweigh the benefits? Let’s spark a conversation in the comments—your perspective matters!
